This is an old revision of the document!
ID Biomedical
ID Biomedical is a Canadian subsidiary of GlaxoSmithKline based in Sainte-Foy, Quebec.1)
Formerly based in Vancouver, British Columbia, the company was bought by GSK in 2005 for $1.7 billion.2) 3)
1)
Health Canada. (2014, July 21). Summary Report - ID Biomedical Corporate of Quebec (GSK). Government of Canada. https://web.archive.org/web/20220428153830/https://www.canada.ca/en/health-canada/services/drugs-health-products/compliance-enforcement/good-manufacturing-practices/summary-report-biomedical-corporate-quebec.html
2)
GlaxoSmithKline buys Vancouver’s ID Biomedical for $1.7 billion. (2005, September 7). CBC News. https://www.cbc.ca/news/business/glaxosmithkline-buys-vancouver-s-id-biomedical-for-1-7-billion-1.534195
3)
FOI Request - HTH-2015-51828. (2016, February 12). Government of British Columbia. https://web.archive.org/web/20220428045844/http://docs.openinfo.gov.bc.ca/Response_Package_HTH-2015-51828.pdf